Second-Line Therapy for Type 2 Diabetes Management: The Treatment/Benefit Paradox of Cardiovascular and Kidney Comorbidities. uri icon

authors

  • McCoy, Rozalina G
  • Van Houten, Holly K
  • Karaca-Mandic, Pinar
  • Joseph S. Ross, MD, MHS
  • Montori, Victor M
  • Shah, Nilay D

publication date

  • August 4, 2021